Clinical trial Recruiting at 1 site Observational Ages 18 to 100

Tissue bank for human blood cell disorders

Official title: Human Blood Cell Disorders Tissue Bank

Run by Northwell Health · NCT00902447 · Data updated 2026-11-12

This study is creating a tissue bank of blood samples from patients with blood cell disorders so researchers can learn more about these conditions and how they compare to healthy blood cells.

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment10000 (estimated)
SponsorNorthwell Health
Academic / other
Locations1 site (Manhasset, New York)
StatusRecruiting
StartedApril 2009
Main results expectedJanuary 2030
Study endsJanuary 2035
Registry record updatedMarch 27, 2024
Trial IDNCT00902447 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients diagnosed with lymphoid, myeloid, or erythroid proliferative diseases who can provide informed consent and contribute tissue samples.

Probably not a fit

Patients who are anemic with hemoglobin levels below 8.0 g/dl or those infected with HIV may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Human Blood Cell Disorder Tissue Bank aims to create a comprehensive repository of tissue samples containing various populations of human blood cells from patients with lymphoid, myeloid, and erythroid proliferative diseases. This observational study will allow internal and external researchers to access these samples to investigate the immunologic, virologic, genetic, and molecular characteristics of both abnormal and normal blood cells. The goal is to enhance understanding of blood cell disorders and facilitate better comparisons with normal cellular counterparts.

Why it matters

Potential benefit: If successful, this tissue bank could significantly advance the understanding and treatment of various blood cell disorders.

How similar studies have gone: While similar tissue banks have been established, the specific focus on human blood cell disorders may provide novel insights into these conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants or participant's Legally Authorized Representatives (LAR) must be able to understand and render voluntary, written informed consent.
* Patients must be able to contribute the required amount of blood and/or tissue without compromising their well-being or care.
* Participants must be willing to be contacted again for consideration of additional studies in the future, such as a blood draw or another action (e.g., bone marrow aspiration and/or biopsy) that would be done as part of their standard of care.

Exclusion Criteria:

* Patients who are known to be anemic, with hemoglobin \<8.0g/dl.
* Patients who are known to be infected with HIV.

Where it's running

  • The Feinstein Institute for Medical Research
    Manhasset, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Nicholas Chiorazzi, M.D. — Northwell Health
  • Study coordinator: Yasmine Kieso, MSCR
  • Email: ykieso@northwell.edu

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.